Talphera (TLPH) Cash from Financing Activities (2010 - 2026)

Talphera's (TLPH) quarterly Cash from Financing Activities came in at $4.0 million in Q1 2026, up 80960.0% year-on-year from N/an in Q1 2025, and up 188.17% quarter-over-quarter from $1.4 million in Q4 2025.

Talphera (TLPH) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Talphera's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $4.0 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 80960.0% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $26.8 million, a 107052.0% increase from a year earlier, with the FY2025 full-year figure at $22.7 million, up 88.81% from the prior year.
  • Cash from Financing Activities rose to $4.0 million in Q1 2026 per TLPH's latest filing, from $1.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $17.0 million in Q3 2025 and bottomed at -$3.3 million in Q2 2023.
  • The 5-year median for Cash from Financing Activities is $30000.0 (2024), against an average of $2.8 million.
  • Across the five-year window, Cash from Financing Activities plunged 106.09% in 2022 and surged 80960.0% in 2026, its largest moves.
  • Year by year, Cash from Financing Activities stood at $5.3 million in 2022, then sank by 101.28% to -$68000.0 in 2023, then soared by 144.12% to $30000.0 in 2024, then jumped by 4576.67% to $1.4 million in 2025, then surged by 188.17% to $4.0 million in 2026.
  • Per Business Quant, the three latest TLPH Cash from Financing Activities figures stand at $4.0 million (Q1 2026), $1.4 million (Q4 2025), and $17.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Talphera 47.31 Mn 9.48 Mn - 4.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.04 Mn
Mar 31, 2026 4.04 Mn
Dec 31, 2025 1.40 Mn
Dec 31, 2025 1.40 Mn
Sep 30, 2025 16.99 Mn
Sep 30, 2025 16.99 Mn
Jun 30, 2025 4.35 Mn
Jun 30, 2025 4.35 Mn
Mar 31, 2025 -5,000.00
Mar 31, 2025 -5,000.00
Sep 30, 2024 30,000.00
Sep 30, 2024 30,000.00
Mar 31, 2024 12.01 Mn
Mar 31, 2024 12.01 Mn
Dec 31, 2023 -68,000.00
Dec 31, 2023 -68,000.00
Sep 30, 2023 8.94 Mn
Sep 30, 2023 8.94 Mn
Jun 30, 2023 -3.33 Mn
Jun 30, 2023 -3.33 Mn